Voluntary nationwide recall: Dexcom G7 sensors (June 2026)

Jun. 2026Pharmacy Updates

Dexcom, Inc. is recalling two lots of Dexcom G7 sensors. Dexcom G7 sensors are used to monitor blood glucose levels as part of the Dexcom Glucose Monitoring system.

This product is being recalled because lots 1725204004 and 1725069002 were intended for destruction but were stolen and sold by a third party. Lot 1725204004 may include sensors that are not properly sterilized and have an increased risk of skin infection. Lot 1725069002 may include sensors that do not have sensor readings available.

To see if your product was recalled, contact your doctor or the pharmacy where you received it. You can also visit the FDA website below or dexcom.com/theft-check.

If you have an affected lot of Dexcom G7 sensors or are experiencing any problems that may be related to receiving the product, Dexcom says you should stop using the sensors and call Dexcom Customer Support at 844-478-1600 to request replacement sensors.

As of May 29, there had been no reports of adverse events related to this recall.

To learn more about this recall, you can take one or more of the steps below.

  • Talk to your doctor or pharmacist.
  • Call Dexcom Customer Support at 844-478-1600. TTY users should call 711.

Recent Announcements

Virtual Institute: Bridging the Gap: Foundations of Integrated Care CME Courses Available

Bridging the Gap: Foundations of Integrated Healthcare is a free educational series designed to support behavioral health and physical health providers in integrating physical health and wellness strategies into their practices and programs to support recovery of individuals living with serious mental illnesses. The series emphasizes tools, education, and resources that empower healthcare providers and individuals to become informed and effective managers of their health and health care.
Jun. 2026Education/Webinars

Important information regarding Medicare GLP-1 Bridge through CMS

The Centers for Medicare & Medicaid Services (CMS) is expanding access to certain GLP-1 medications through the Medicare GLP-1 Bridge short-term demonstration starting July 1, 2026.
Jun. 2026Important Notices

CME/CEU Webinar: Bright Beginnings: The Role of Medical and Dental Providers in Early Oral Health

Please join us for a live, CME-accredited and CEU-accredited webinar on Monday, Aug. 24 from noon to 1 p.m., that will educate providers on the importance of early childhood oral health.
Jun. 2026Education/Webinars